CTAD: Updating the Definition—and Diagnostic Criteria—of Alzheimer’s
Driven by advances in new biomarker detection technologies and the approval of Leqembi — a disease-modifying therapy — scientists are updating the definition of…
Driven by advances in new biomarker detection technologies and the approval of Leqembi — a disease-modifying therapy — scientists are updating the definition of…
For people living with dementia and their caregivers, the term Mild Cognitive Impairment (MCI) may be familiar. Often the first diagnosis many patients receive,…
The science behind Alzheimer’s is constantly developing, but its cause remains elusive and the disease is frequently misdiagnosed. A 2017 study at a hospital…
There are a few new drugs out there that can actually slow down Alzheimer’s disease. But, by the time around half of Americans get…
Getting an accurate diagnosis for a neurodegenerative disease like Alzheimer’s or another form of dementia early in the journey can make a huge difference…
A new way of defining for Alzheimer’s could help patients receive an early and accurate diagnosis. Clinicians presented a draft of a new definition…
After my mom was first diagnosed with Alzheimer’s disease, I spent much of the first several years wondering if she really had Alzheimer’s. Her…
One day, Don Kent’s personality started changing. A cool, even-keeled lawyer, he found himself suddenly losing control of his emotions. At the same time,…
Editor’s note: Dr. Marwan Sabbagh will join Being Patient again on September 19, 2023 to revisit this topic and discuss dementia misdiagnosis, why it’s…
If you could get a $400 blood test that tells you within 10 days whether you’re likely to develop Alzheimer’s disease years or decades…
Right now, a definitive Alzheimer’s diagnosis can only be obtained through the detection of beta-amyloid levels in the brain — clumps of a protein…
It was 7:20 a.m. and Joel Braunstein, co-founder and CEO of C2N Diagnostics, was about to start his second meeting of the day. C2N…
Good news for brain health this summer: FDA-approved drugs like Leqembi available for Alzheimer’s are becoming more widely available. The caveat: These drugs only…
Today, more than 55 million people are living with Alzheimer’s disease globally. In the U.S., one in 10 people over the age of 65,…
Especially as the recent launch of ChatGPT — an alarmingly smart, artificial intelligence-powered text generator that can write a school term paper about as…